Concepedia

Michael L. Grossbard

ML

62

Publications

4.9K

Citations

33

H-Index

1987

Active since

Affiliations

Massachusetts General Hospital(Current)

St. Luke's-Roosevelt Hospital Center

Dana-Farber Cancer Institute

Harvard University

Mount Sinai Beth Israel

Michael L. Grossbard is an author at Massachusetts General Hospital specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

1987–2021

62

Publications

62

Immunologic Purging of Marrow Assessed by PCR before Autologous Bone Marrow Transplantation for B-Cell Lymphoma

John G. Gribben, Arnold S. Freedman, Donna Neuberg et al. · New England Journal of Medicine · 1991 · 686 citations · Full text

Phase II Study of Rituximab in Combination With CHOP Chemotherapy in Patients With Previously Untreated, Aggressive Non-Hodgkin’s Lymphoma

Julie M. Vose, Brian K. Link, Michael L. Grossbard et al. · Journal of Clinical Oncology · 2001 · 416 citations

Rituximab and CHOP Induction Therapy for Newly Diagnosed Mantle-Cell Lymphoma: Molecular Complete Responses Are Not Predictive of Progression-Free Survival

Orion M. Howard, John G. Gribben, Donna Neuberg et al. · Journal of Clinical Oncology · 2002 · 347 citations

Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy

Wyndham H. Wilson, Michael L. Grossbard, Stefania Pittaluga et al. · Blood · 2002 · 325 citations

Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer.

Noah C. Choi, Robert W. Carey, William J. Daly et al. · Journal of Clinical Oncology · 1997 · 272 citations

Rows per page

1–5 of 62